These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16415982)

  • 1. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
    Warfield KL; Swenson DL; Olinger GG; Nichols DK; Pratt WD; Blouch R; Stein DA; Aman MJ; Iversen PL; Bavari S
    PLoS Pathog; 2006 Jan; 2(1):e1. PubMed ID: 16415982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
    Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
    Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
    mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.
    Swenson DL; Warfield KL; Warren TK; Lovejoy C; Hassinger JN; Ruthel G; Blouch RE; Moulton HM; Weller DD; Iversen PL; Bavari S
    Antimicrob Agents Chemother; 2009 May; 53(5):2089-99. PubMed ID: 19223614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation in nonhuman primates of vaccines against Ebola virus.
    Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
    Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
    Wilson JA; Bray M; Bakken R; Hart MK
    Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
    Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
    Geisbert TW; Hensley LE
    Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.
    Geisbert TW; Lee AC; Robbins M; Geisbert JB; Honko AN; Sood V; Johnson JC; de Jong S; Tavakoli I; Judge A; Hensley LE; Maclachlan I
    Lancet; 2010 May; 375(9729):1896-905. PubMed ID: 20511019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.
    Qiu X; Audet J; Wong G; Pillet S; Bello A; Cabral T; Strong JE; Plummer F; Corbett CR; Alimonti JB; Kobinger GP
    Sci Transl Med; 2012 Jun; 4(138):138ra81. PubMed ID: 22700957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.
    Iversen PL; Warren TK; Wells JB; Garza NL; Mourich DV; Welch LS; Panchal RG; Bavari S
    Viruses; 2012 Nov; 4(11):2806-30. PubMed ID: 23202506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Characterization of Defective Viral Genomes in Ebola Virus-Infected Rhesus Macaques.
    Johnson RI; Boczkowska B; Alfson K; Weary T; Menzie H; Delgado J; Rodriguez G; Carrion R; Griffiths A
    J Virol; 2021 Aug; 95(17):e0071421. PubMed ID: 34160256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.
    Olszanecki R; Gawlik G
    Folia Med Cracov; 2014; 54(3):67-77. PubMed ID: 25694097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.
    Cao Z; Liu C; Peng C; Ran Y; Yao Y; Xiao G; Li E; Chen Z; Chuai X; Chiu S
    Virol Sin; 2023 Dec; 38(6):922-930. PubMed ID: 37839549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.